Literature DB >> 15226403

ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.

Akira Motegi1, Jiro Fujimoto, Masaharu Kotani, Hitoshi Sakuraba, Tadashi Yamamoto.   

Abstract

Anaplastic lymphoma kinase (ALK) is a receptor-type protein tyrosine kinase that is expressed preferentially in neurons of the central and peripheral nervous systems at late embryonic stages. To elucidate the role of ALK in neurons, we developed an agonist monoclonal antibody (mAb) against the extracellular domain of ALK. Here we show that mAb16-39 elicits tyrosine phosphorylation of endogenously expressed ALK in human neuroblastoma (SK-N-SH) cells. Stimulation of these cells with mAb16-39 markedly induces the tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), Shc, and c-Cbl and also their interaction with ALK and activation of ERK1/2. Furthermore, we show that continuous incubation with mAb16-39 induces the cell growth and neurite outgrowth of SK-N-SH cells. These responses are completely blocked by MEK inhibitor PD98059 but not by the phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor wortmannin, indicating an essential role of the mitogen-activated protein kinase (MAP kinase) signaling cascade in ALK-mediated growth and differentiation of neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226403     DOI: 10.1242/jcs.01183

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  57 in total

Review 1.  Emerging importance of ALK in neuroblastoma.

Authors:  Anna M Azarova; Gargi Gautam; Rani E George
Journal:  Semin Cancer Biol       Date:  2011-09-16       Impact factor: 15.707

2.  The beta isotypes of tubulin in neuronal differentiation.

Authors:  Jiayan Guo; Consuelo Walss-Bass; Richard F Ludueña
Journal:  Cytoskeleton (Hoboken)       Date:  2010-07

3.  Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system.

Authors:  Shawn P Hurley; Douglas O Clary; Valerie Copie; Frances Lefcort
Journal:  J Comp Neurol       Date:  2006-03-10       Impact factor: 3.215

Review 4.  ALK alterations and inhibition in lung cancer.

Authors:  Tri Le; David E Gerber
Journal:  Semin Cancer Biol       Date:  2016-09-13       Impact factor: 15.707

5.  The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.

Authors:  Matthew J Smith; W Rod Hardy; Guang-Yao Li; Marilyn Goudreault; Steven Hersch; Pavel Metalnikov; Andrei Starostine; Tony Pawson; Mitsuhiko Ikura
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

6.  Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Hypothalamic Neurones Provides Developmental Insights into Genetic Loci for Body Weight Regulation.

Authors:  L Yao; Y Liu; Z Qiu; S Kumar; J E Curran; J Blangero; Y Chen; D M Lehman
Journal:  J Neuroendocrinol       Date:  2017-02       Impact factor: 3.627

7.  ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.

Authors:  Shou-Wei Jia; Sha Fu; Fang Wang; Qiong Shao; Hong-Bing Huang; Jian-Yong Shao
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 8.  New insights into the genetics of neuroblastoma.

Authors:  Srishma Sridhar; Batool Al-Moallem; Hawra Kamal; Marta Terrile; Raymond L Stallings
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074

9.  Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.

Authors:  Soeren Latteyer; Vera Tiedje; Katharina König; Saskia Ting; Lukas C Heukamp; Lydia Meder; Kurt Werner Schmid; Dagmar Führer; Lars Christian Moeller
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.